Verrica Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

Verrica Pharmaceuticals

13/05/2024 14:52

* Verrica Pharmaceuticals Inc  VRCA.OQ  reported a quarterly
adjusted loss of 44 cents​​ per share for the quarter ended in
March, lower than the same quarter last year, when the company
reported EPS of -15 cents.  The mean expectation of
five analysts for the quarter was for a loss of 40 cents per
share. Wall Street expected results to range from -51 cents
to -29 cents per share.
    * Revenue rose 10,240.5% to $3.83 million from a year ago;
analysts expected $2.78 million. 
    * Verrica Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 44 cents​.
    * The company reported a quarterly loss of $20.33 million.
    * Verrica Pharmaceuticals Inc shares had risen by 35.1% this
quarter and gained 9.3% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 15.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Verrica
Pharmaceuticals Inc is $13.50 
This summary was machine generated from LSEG data May 13 at
01:52 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.40          -0.44          Missed
 Dec. 31 2023      -0.53          -0.53          Met
 Sep. 30 2023      -0.36          -0.54          Missed
 Jun. 30 2023      -0.21          -0.24          Missed